Both, PAI-1 activity in plasma (~+3.3-fold, p < 0.05) and CRP serum levels (~+2-fold, p < 0.05) were significantly higher in children with early signs of NAFLD than in controls. The gene discussed is SERPINE1; the disease is metabolic dysfunction-associated steatotic liver disease.